- Report
- July 2022
- 120 Pages
North America
From €3092EUR$3,450USD£2,695GBP
- Report
- July 2022
- 132 Pages
Europe
From €3092EUR$3,450USD£2,695GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3092EUR$3,450USD£2,695GBP
- Report
- March 2022
- 198 Pages
Global
From €3988EUR$4,450USD£3,477GBP
- Report
- February 2022
- 174 Pages
Global
From €3988EUR$4,450USD£3,477GBP
- Report
- February 2026
- 150 Pages
Canada
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
China
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
Germany
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
India
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
Canada
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
China
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 150 Pages
India
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 173 Pages
Canada
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 182 Pages
China
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 174 Pages
Germany
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 175 Pages
India
From €4347EUR$4,850USD£3,789GBP
- Report
- February 2026
- 178 Pages
Japan
From €4347EUR$4,850USD£3,789GBP
- Report
- January 2026
- 150 Pages
Japan
From €4347EUR$4,850USD£3,789GBP
- Report
- January 2026
- 150 Pages
India
From €4347EUR$4,850USD£3,789GBP
- Report
- December 2025
- 150 Pages
Germany
From €4347EUR$4,850USD£3,789GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more